Clinical trial
Pharmacological Intervention for Atrial Arrhythmias to Prevent New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement: A Prospective, Multicenter, Randomized Controlled Trial
NCT07519161 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacological Intervention for Atrial Arrhythmias to Prevent New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement: A Prospective, Multicenter, Randomized Controlled Trial
- Lead sponsor
- Shanghai East Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- April 7, 2026
- Completion date
- March 31, 2030
- Enrollment
- 198 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.